Robert de Man

2.2k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Robert de Man is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Robert de Man has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Robert de Man's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Robert de Man is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Robert de Man collaborates with scholars based in Netherlands, United States and Argentina. Robert de Man's co-authors include Robert G. Gish, Adrián Gadano, You‐Chen Chao, Kwang‐Hyub Han, Zachary Goodman, Ting‐Tsung Chang, Anna S. Lok, Jin Liang Zhu, Richard B. Wilber and Deborah DeHertogh and has published in prestigious journals such as New England Journal of Medicine, Journal of Hepatology and British journal of surgery.

In The Last Decade

Robert de Man

20 papers receiving 1.5k citations

Hit Papers

A Comparison of Entecavir and Lamivudine for HBeAg-Positi... 2006 2026 2012 2019 2006 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert de Man Netherlands 11 1.3k 1.3k 171 163 145 21 1.6k
Eva Martínez‐Bauer Spain 13 1.4k 1.0× 1.4k 1.1× 263 1.5× 72 0.4× 95 0.7× 39 1.7k
Yoshiyuki Suzuki Japan 9 797 0.6× 784 0.6× 210 1.2× 173 1.1× 104 0.7× 20 1.0k
Giuseppe Morelli United States 19 912 0.7× 788 0.6× 351 2.1× 95 0.6× 195 1.3× 52 1.3k
T Bizollon France 18 1.7k 1.3× 1.4k 1.1× 465 2.7× 45 0.3× 91 0.6× 48 1.9k
Mar Riveiro‐Barciela Spain 20 991 0.8× 799 0.6× 46 0.3× 286 1.8× 41 0.3× 100 1.3k
Tony Andréani France 11 962 0.7× 977 0.7× 307 1.8× 79 0.5× 83 0.6× 20 1.2k
Alice Colucci Italy 5 558 0.4× 622 0.5× 215 1.3× 39 0.2× 51 0.4× 7 944
Damien Lucidarme France 16 356 0.3× 597 0.5× 309 1.8× 76 0.5× 120 0.8× 43 1.1k
M. Chevallier France 16 639 0.5× 659 0.5× 164 1.0× 91 0.6× 94 0.6× 35 984
Míriam Romero Spain 19 844 0.6× 787 0.6× 101 0.6× 324 2.0× 20 0.1× 55 1.1k

Countries citing papers authored by Robert de Man

Since Specialization
Citations

This map shows the geographic impact of Robert de Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert de Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert de Man more than expected).

Fields of papers citing papers by Robert de Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert de Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert de Man. The network helps show where Robert de Man may publish in the future.

Co-authorship network of co-authors of Robert de Man

This figure shows the co-authorship network connecting the top 25 collaborators of Robert de Man. A scholar is included among the top collaborators of Robert de Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert de Man. Robert de Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farag, Mina, Margo J. H. van Campenhout, Milan J. Sonneveld, et al.. (2024). Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B. Journal of Viral Hepatitis. 31(4). 197–207. 7 indexed citations
2.
Joliat, Gaëtan‐Romain, Robert de Man, Vincent Rijckborst, et al.. (2024). Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study. British journal of surgery. 111(4). 1 indexed citations
3.
Man, Robert de, et al.. (2022). Epidemiology and management of hepatitis B and C in primary care in the Netherlands-data from the Rijnmond primary care database. Journal of Hepatology. 77. S227–S228. 1 indexed citations
4.
Willemssen, François E.J.A., Quido G. de Lussanet, Daniël Bos, et al.. (2022). Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC. Cancers. 14(16). 3961–3961. 5 indexed citations
5.
Man, Robert de, et al.. (2020). Employment after liver transplantation and contributing factors. Journal of Hepatology. 73. S559–S559. 1 indexed citations
6.
Maan, Raoel, Alnoor Ramji, Michael P. Manns, et al.. (2020). Identification of patients with compensated cirrhosis who can safely use protease inhibitor-based therapy for HCV infection. Journal of Hepatology. 73. S349–S350. 1 indexed citations
7.
Choi, Hannah, Mina Farag, Willem Pieter Brouwer, et al.. (2020). Early PEG-interferon-related ALT flares of high magnitude lead to HBsAg decline and loss. A study of 639 chronic hepatitis B patients. Journal of Hepatology. 73. S866–S866. 3 indexed citations
8.
Borgsteede, Sander D., et al.. (2019). Veilig voorschrijven bij levercirrose. Huisarts en Wetenschap. 62(4). 50–53. 1 indexed citations
9.
Erler, Nicole S., et al.. (2019). SAT-092-The efficacy and safety of rifaximin-a: a 2-year observational study of overt hepatic encephalopathy. Journal of Hepatology. 70(1). e668–e668. 1 indexed citations
10.
Pischke, Sven, Jean‐Marie Péron, Moritz von Wulffen, et al.. (2019). Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study. Viruses. 11(2). 186–186. 30 indexed citations
11.
Ekkelenkamp, Vivian E., Robert de Man, Frank ter Borg, et al.. (2015). Prospective evaluation of ERCP performance: results of a nationwide quality registry. Endoscopy. 47(6). 503–507. 68 indexed citations
12.
Ekkelenkamp, Vivian E., Arjun D. Koch, Erik A. Rauws, et al.. (2014). Competence development in ERCP: the learning curve of novice trainees. Endoscopy. 46(11). 949–955. 56 indexed citations
13.
Chang, Ting‐Tsung, You‐Chen Chao, Kwang‐Hyub Han, et al.. (2009). Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside‐naïve HBeAg‐positive patients with chronic hepatitis B. Journal of Viral Hepatitis. 16(11). 784–789. 20 indexed citations
14.
Gish, Robert G., Ting‐Shou Chang, Ching‐Lung Lai, et al.. (2009). Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*. Journal of Viral Hepatitis. 17(1). 16–22. 109 indexed citations
15.
Kuiper, Jonas J. W., et al.. (2008). Components of the renin‐angiotensin‐aldosterone system in plasma and ascites in hepatic cirrhosis. European Journal of Clinical Investigation. 38(12). 939–944. 19 indexed citations
16.
Chang, Ting‐Tsung, Robert G. Gish, Robert de Man, et al.. (2006). A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine. 354(10). 1001–1010. 1064 indexed citations breakdown →
17.
Bacher, Klaus, Peter Smeets, L Vereecken, et al.. (2006). Image Quality and Radiation Dose on Digital Chest Imaging: Comparison of Amorphous Silicon and Amorphous Selenium Flat-Panel Systems. American Journal of Roentgenology. 187(3). 630–637. 40 indexed citations
18.
Willems, M., et al.. (2002). Liver transplantation and hepatitis C. Transplant International. 15(2-3). 61–72. 33 indexed citations
19.
Rave, Sjoerd de, Hugo W. Tilanus, Joke van der Linden, et al.. (2002). The importance of orthotopic liver transplantation in acute hepatic failure. Transplant International. 15(1). 29–33. 25 indexed citations
20.
Mutimer, David, Pieter Honkoop, George Marinos, et al.. (1998). Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. Journal of Hepatology. 28(6). 923–929. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026